Jabbour Reports Top Takeaways From ASH 2023 of Olverembatinib in CML and ALL

Welcome to OncLive On Air^®! I’m your host today, Ryan Scott.

OncLive On Air is a podcast from OncLive^®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, sponsored by Ascentage Pharma, we had the pleasure of speaking with Elias Jabbour, MD, a professor in the Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, Texas.

In our exclusive interview, Dr Jabbour discussed the activity and the utilization of olverembatinib (HQP1351) in chronic myeloid leukemia (CML); highlighted the implementation of third-generation TKIs like olverembatinib in this patient population; and expanded upon the role that TKIs can play in the management of malignancies beyond CML and acute lymphoblastic leukemia (ALL).

___

That’s all we have for today! Thank you for listening to this episode of OncLive On Air, sponsored by Ascentage Pharma. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air.

*OncLive On Air is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.